White label ELPA - ClinicalTrials.eu

Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Endometrial cancer
Investigated drugs:
+9
Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

Not recruiting

1 1 1 1
Investigated diseases:
- Renal cell carcinoma
Investigated drugs:
Study of Nivolumab and Ipilimumab for Patients with Advanced Liver Cancer (Hepatocellular Carcinoma) as First-Line Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Hepatocellular carcinoma
Investigated drugs:
+2
Study on the Safety and Effects of Englumafusp Alfa with Obinutuzumab and Glofitamab for Patients with Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- B-cell lymphoma
- B-cell lymphoma refractory
Investigated drugs:
Study of ALX148 with Trastuzumab, Ramucirumab, and Paclitaxel for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Not recruiting

4 1 1
Investigated diseases:
- Gastric cancer
Investigated drugs:
Study on the Effects and Safety of Rilzabrutinib for Adults with Warm Autoimmune Hemolytic Anemia

Not recruiting

2 1 1
Investigated diseases:
- Autoimmune haemolytic anaemia
Investigated drugs:
- Rilzabrutinib
Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

Not recruiting

3 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+2
Study on Sodium Zirconium Cyclosilicate for Patients with Chronic Kidney Disease Stages 3b and 4 to Allow More Fruits and Vegetables in Their Diet

Not recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Sodium Zirconium Cyclosilicate
Long-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen

Not recruiting

2 1 1
Investigated diseases:
- Chronic hepatitis B
Investigated drugs:
- Bepirovirsen
+3
Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Not recruiting

3 1
Investigated drugs:
- Risankizumab
+11

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies